Mirvetuximab
Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1) . Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers.
Product Specifications
CAS Number
1453084-36-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Antifolate
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15185555 1 Vial
Lentiviral mouse Npy shRNA (UAS) - Lentiviral mouse Npy shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details 
ST2150-1g 1 g
5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside (≥99%, Reagent grade)
Sign In for Pricing
View Details I8439-07-ML550 100 µL
Interleukin 17 (IL-17, CTLA8, IL-17A, Interleukin-17A precursor, Cytotoxic T-lymphocyte-associated antigen 8) (MaxLight 550)
Sign In for Pricing
View Details 
MBS7168870 Inquire
Rabbit anti-Escherichia coli O9:H4 (strain HS) DTD Polyclonal Antibody
Sign In for Pricing
View Details 